|
|
Article: BIO-EUROPE 2007 AS BIG PHARMA MODEL FALTERS, BIOTECH RIDES TO THE RESCUE.
- Article from:
- BIOWORLD Today
- Article date:
- November 13, 2007
- Author:
CopyrightCOPYRIGHT 2007 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Byline: Glen Harris, Managing Editor
HAMBURG, Germany - Vaughn Kailian, general partner at MPM Capital, wasted little time getting to the point at the opening session of BIO-Europe 2007. "What is it about big pharma that allows the strong to become weak and the weak to become strong?" he asked the panel.
Kailian's reference was to the dwindling product pipelines at large pharmaceutical companies, and while it was clearly intended as a devil's advocate question, it produced no vehement rebuttals even from big pharma representatives at Monday's panel on "The Changing World Order of Biotech-Pharma."
The question wasn't surprising to John ...